These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 17694434)

  • 21. Behavioural retardation in the neuropathology of mental retardation.
    Archer T
    APMIS Suppl; 1993; 40():35-56. PubMed ID: 7906129
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Behavioral differences between neonatal and adult 6-hydroxydopamine-treated rats to dopamine agonists: relevance to neurological symptoms in clinical syndromes with reduced brain dopamine.
    Breese GR; Baumeister AA; McCown TJ; Emerick SG; Frye GD; Crotty K; Mueller RA
    J Pharmacol Exp Ther; 1984 Nov; 231(2):343-54. PubMed ID: 6149306
    [TBL] [Abstract][Full Text] [Related]  

  • 23. S 16924 ((R)-2-[1-[2-(2,3-dihydro-benzo[1,4] dioxin-5-Yloxy)-ethyl]-pyrrolidin-3yl]-1-(4-fluoro-phenyl)-ethanone), a novel, potential antipsychotic with marked serotonin (5-HT)1A agonist properties: I. Receptorial and neurochemical profile in comparison with clozapine and haloperidol.
    Millan MJ; Gobert A; Newman-Tancredi A; Audinot V; Lejeune F; Rivet JM; Cussac D; Nicolas JP; Muller O; Lavielle G
    J Pharmacol Exp Ther; 1998 Sep; 286(3):1341-55. PubMed ID: 9732398
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Maze learning and motor activity deficits in adult mice induced by iron exposure during a critical postnatal period.
    Fredriksson A; Schröder N; Eriksson P; Izquierdo I; Archer T
    Brain Res Dev Brain Res; 2000 Jan; 119(1):65-74. PubMed ID: 10648873
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Subchronic treatment with haloperidol and clozapine in rats with neonatal excitotoxic hippocampal damage.
    Lipska BK; Weinberger DR
    Neuropsychopharmacology; 1994 May; 10(3):199-205. PubMed ID: 7916917
    [TBL] [Abstract][Full Text] [Related]  

  • 26. S18327 (1-[2-[4-(6-fluoro-1, 2-benzisoxazol-3-yl)piperid-1-yl]ethyl]3-phenyl imidazolin-2-one), a novel, potential antipsychotic displaying marked antagonist properties at alpha(1)- and alpha(2)-adrenergic receptors: II. Functional profile and a multiparametric comparison with haloperidol, clozapine, and 11 other antipsychotic agents.
    Millan MJ; Brocco M; Rivet JM; Audinot V; Newman-Tancredi A; Maiofiss L; Queriaux S; Despaux N; Peglion JL; Dekeyne A
    J Pharmacol Exp Ther; 2000 Jan; 292(1):54-66. PubMed ID: 10604931
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of co-administration of anticonvulsant and putative anticonvulsive agents and sub/suprathreshold doses of L-dopa upon motor behaviour of MPTP-treated mice.
    Fredriksson A; Palomo T; Archer T
    J Neural Transm (Vienna); 1999; 106(9-10):889-909. PubMed ID: 10599871
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Co-release of noradrenaline and dopamine from noradrenergic neurons in the cerebral cortex induced by clozapine, the prototype atypical antipsychotic.
    Devoto P; Flore G; Vacca G; Pira L; Arca A; Casu MA; Pani L; Gessa GL
    Psychopharmacology (Berl); 2003 Apr; 167(1):79-84. PubMed ID: 12632247
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacology of fluperlapine compared with clozapine.
    Eichenberger E
    Arzneimittelforschung; 1984; 34(1A):110-3. PubMed ID: 6145425
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modulation of the motor response to dopaminergic drugs in a parkinsonian model of combined dopaminergic and noradrenergic degeneration.
    Pérez V; Sosti V; Rubio A; Barbanoj M; Rodríguez-Alvarez J; Kulisevsky J
    Eur J Pharmacol; 2007 Dec; 576(1-3):83-90. PubMed ID: 17888901
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Behavior, neurotransmitters and inflammation in three regimens of the MPTP mouse model of Parkinson's disease.
    Luchtman DW; Shao D; Song C
    Physiol Behav; 2009 Aug; 98(1-2):130-8. PubMed ID: 19410592
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of subchronic, intermittent L-DOPA treatment on neuronal nitric oxide synthase and soluble guanylyl cyclase expression and activity in the striatum and midbrain of normal and MPTP-treated mice.
    Chalimoniuk M; Langfort J
    Neurochem Int; 2007 May; 50(6):821-33. PubMed ID: 17379358
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Striatal extracellular dopamine levels and behavioural reversal in MPTP-lesioned mice.
    Kirchhoff J; Mørk A; Brennum LT; Sager TN
    Neuroreport; 2009 Mar; 20(5):482-6. PubMed ID: 19262413
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Activation of noradrenergic locus coeruleus neurons by clozapine and haloperidol: involvement of glutamatergic mechanisms.
    Nilsson LK; Schwieler L; Engberg G; Linderholm KR; Erhardt S
    Int J Neuropsychopharmacol; 2005 Sep; 8(3):329-39. PubMed ID: 15737250
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Further validation of LABORAS using various dopaminergic manipulations in mice including MPTP-induced nigro-striatal degeneration.
    Quinn LP; Stean TO; Chapman H; Brown M; Vidgeon-Hart M; Upton N; Billinton A; Virley DJ
    J Neurosci Methods; 2006 Sep; 156(1-2):218-27. PubMed ID: 16626808
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Electrophysiological profile of the new atypical neuroleptic, sertindole, on midbrain dopamine neurones in rats: acute and repeated treatment.
    Skarsfeldt T
    Synapse; 1992 Jan; 10(1):25-33. PubMed ID: 1346943
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Striatal adenosine A(2A) receptor blockade increases extracellular dopamine release following l-DOPA administration in intact and dopamine-denervated rats.
    Gołembiowska K; Dziubina A
    Neuropharmacology; 2004 Sep; 47(3):414-26. PubMed ID: 15275831
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neurobehavioural deficits following postnatal iron overload: II Instrumental learning performance.
    Archer T; Schröder N; Fredriksson A
    Neurotox Res; 2003; 5(1-2):77-94. PubMed ID: 14628858
    [No Abstract]   [Full Text] [Related]  

  • 39. Endogenous neurotensin attenuates dopamine-dependent locomotion and stereotypy.
    Chartoff EH; Szczypka MS; Palmiter RD; Dorsa DM
    Brain Res; 2004 Oct; 1022(1-2):71-80. PubMed ID: 15353215
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Involvement of cholinergic system in hyperactivity in dopamine-deficient mice.
    Hagino Y; Kasai S; Fujita M; Setogawa S; Yamaura H; Yanagihara D; Hashimoto M; Kobayashi K; Meltzer HY; Ikeda K
    Neuropsychopharmacology; 2015 Mar; 40(5):1141-50. PubMed ID: 25367503
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.